Cargando…

Association between leptin levels and severity of suicidal behaviour in schizophrenia spectrum disorders

OBJECTIVE: Associations between suicidality and lipid dysregulation are documented in mental illness, but the potential role of leptin remains unclear. We examined the association between leptin and suicidal behaviour in schizophrenia, together with the influence of other clinical and biological ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gohar, S. M., Dieset, I., Steen, N. E., Mørch, R. H., Vedal, T. S. J., Reponen, E. J., Steen, V. M., Andreassen, O. A., Melle, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593433/ https://www.ncbi.nlm.nih.gov/pubmed/30848483 http://dx.doi.org/10.1111/acps.13019

Ejemplares similares

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

F22. DYSLIPIDEMIA AND INFLAMMATORY MARKERS IN RELATION TO CLINICAL SYMPTOMATOLOGY IN PSYCHOTIC DISORDERS
por: Gohar, Sherif M, et al.
Publicado: (2018)

Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders
por: Gohar, Sherif M., et al.
Publicado: (2018)

Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
por: Reponen, Elina J., et al.
Publicado: (2020)

Attenuated Notch signaling in schizophrenia and bipolar disorder
por: Hoseth, Eva Z., et al.
Publicado: (2018)

Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder
por: Hoseth, Eva Z., et al.
Publicado: (2018)

Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
por: Gjerde, Priyanthi B., et al.
Publicado: (2022)

S96. CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
por: Rødevand, Linn, et al.
Publicado: (2018)

T229. ANTIPSYCHOTIC DRUG USE AND THYROID FUNCTION IN PATIENTS WITH SEVERE MENTAL DISORDERS
por: Iversen, Trude, et al.
Publicado: (2018)

Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021)

Serum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting
por: Steen, Nils Eiel, et al.
Publicado: (2016)

Clinical characteristics in schizophrenia patients with or without suicide attempts and non-suicidal self-harm - a cross-sectional study
por: Mork, Erlend, et al.
Publicado: (2013)

Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder
por: Fjukstad, Katrine Kveli, et al.
Publicado: (2016)

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
por: Kroken, Rune A., et al.
Publicado: (2019)

Childhood Trauma Is Nominally Associated With Elevated Cortisol Metabolism in Severe Mental Disorder
por: Aas, Monica, et al.
Publicado: (2020)

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
por: Szabo, Attila, et al.
Publicado: (2020)

Clinical Correlates of Suicide in Suicidal Patients with Schizophrenia Spectrum Disorders and Affective Disorders
por: Singh, Hemendra, et al.
Publicado: (2016)

Disentangling the relationship between cholesterol, aggression, and impulsivity in severe mental disorders
por: Hjell, Gabriela, et al.
Publicado: (2020)

Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review
por: Canal-Rivero, Manuel, et al.
Publicado: (2021)

Contribution of oxytocin receptor polymorphisms to amygdala activation in schizophrenia spectrum disorders
por: Haram, Marit, et al.
Publicado: (2016)

Decision making and implicit suicidality in schizophrenia spectrum disorders
por: Vorontsova, O., et al.
Publicado: (2021)

Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia
por: Bolstad, Albert, et al.
Publicado: (2011)

Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes
por: Torsvik, Anja, et al.
Publicado: (2023)

Reduced prefrontal activity and suicidal behaviour in early schizophrenia
por: Grigoriou, M., et al.
Publicado: (2021)

Reduced load-dependent default mode network deactivation across executive tasks in schizophrenia spectrum disorders
por: Haatveit, Beathe, et al.
Publicado: (2016)

Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients
por: Gjerde, Priyanthi B., et al.
Publicado: (2021)

Suicide prevention in schizophrenia spectrum disorders and psychosis: a systematic review
por: Donker, Tara, et al.
Publicado: (2013)

Neurocognitive Functioning and Suicidal Behavior in Violent Offenders with Schizophrenia Spectrum Disorders
por: Sánchez-Sansegundo, Miriam, et al.
Publicado: (2020)

The Effects of Leptin on Breastfeeding Behaviour
por: Cannon, Anna M., et al.
Publicado: (2015)

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
por: Ringen, Petter Andreas, et al.
Publicado: (2014)

Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients
por: Gjerde, Priyanthi B., et al.
Publicado: (2019)

Therapeutic alliance in early schizophrenia spectrum disorders: a cross-sectional study
por: Johansen, Ragnhild, et al.
Publicado: (2013)

Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders
por: Lyngstad, Siv Hege, et al.
Publicado: (2023)

Unrecognized schizophrenia spectrum and other mental disorders in youth disconnected from education and work-life
por: Lindhardt, Line, et al.
Publicado: (2022)

Visual processing deficits in patients with schizophrenia spectrum and bipolar disorders and associations with psychotic symptoms, and intellectual abilities
por: Løchen, Aili R., et al.
Publicado: (2023)

Lep gene and leptin concentration in serum of schizophrenia patients with metabolic syndrome
por: Boiko, A., et al.
Publicado: (2021)

Telomere length is associated with childhood trauma in patients with severe mental disorders
por: Aas, Monica, et al.
Publicado: (2019)

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
por: Okhuijsen-Pfeifer, C., et al.
Publicado: (2022)

Neurocognitive Suicide and Homicide Markers in Patients with Schizophrenia Spectrum Disorders: A Systematic Review
por: Tomé-Fernández, Mario, et al.
Publicado: (2023)

Association between suicidal ideation and cognitive function in young patients with schizophrenia spectrum disorder
por: Kim, Ji-Su, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5k90dvdn7g44pkedjg7k4nfdq